Raychaudhuri, S., Othus, M., Percival, M.-E., Garcia-Manero, G., Appelbaum, F. R., Erba, H. P., & Appelbaum, J. S. (2025). Treatment discontinuation due to toxicity for patients with acute myeloid leukemia receiving intensive chemotherapy. Blood Neoplasia, 2(3), 100129. https://doi.org/10.1016/j.bneo.2025.100129

Raychaudhuri, Suravi, Megan Othus, Mary-Elizabeth M. Percival, Guillermo Garcia-Manero, Frederick R. Appelbaum, Harry P. Erba, and Jacob S. Appelbaum. “Treatment discontinuation due to toxicity for patients with acute myeloid leukemia receiving intensive chemotherapy.” Blood Neoplasia 2, no. 3 (August 2025): 100129. https://doi.org/10.1016/j.bneo.2025.100129.

Raychaudhuri S, Othus M, Percival M-EM, Garcia-Manero G, Appelbaum FR, Erba HP, et al. Treatment discontinuation due to toxicity for patients with acute myeloid leukemia receiving intensive chemotherapy. Blood Neoplasia. 2025 Aug;2(3):100129.

Raychaudhuri, Suravi, et al. “Treatment discontinuation due to toxicity for patients with acute myeloid leukemia receiving intensive chemotherapy.” Blood Neoplasia, vol. 2, no. 3, Aug. 2025, p. 100129. Pubmed, doi:10.1016/j.bneo.2025.100129.

Raychaudhuri S, Othus M, Percival M-EM, Garcia-Manero G, Appelbaum FR, Erba HP, Appelbaum JS. Treatment discontinuation due to toxicity for patients with acute myeloid leukemia receiving intensive chemotherapy. Blood Neoplasia. 2025 Aug;2(3):100129.